Effects of Troglitazone on Heart Function in Diabetic Rats
Author Information
Author(s): Anzawa Ryuko, Seki Shingo, Horikoshi Kazuaki, Taniguchi Masayuki, Mochizuki Seibu
Primary Institution: The Jikei University School of Medicine
Hypothesis
The study investigates the relationship between ischemia-induced arrhythmia and intracellular pH changes in type 2 diabetic hearts.
Conclusion
Troglitazone treatment improved ischemic tolerance by enhancing glucose metabolism in the hearts of diabetic OLETF rats.
Supporting Evidence
- OLETF rats showed longer duration of reperfusion-induced ventricular fibrillation compared to LETO rats.
- Troglitazone treatment improved pH levels and reduced proton production during ischemia.
- Diabetic OLETF rats exhibited impaired glucose tolerance and obesity at 32 weeks of age.
- Reperfusion arrhythmia incidence was significantly higher in OLETF rats at 32 weeks.
Takeaway
Diabetic rats have hearts that are more sensitive to damage when blood flow is restored after being cut off, but a medicine called troglitazone can help make their hearts stronger.
Methodology
The study used male OLETF and LETO rats, inducing ischemia in their hearts and measuring various physiological parameters.
Potential Biases
Potential bias in the selection of animal models and treatment effects.
Limitations
The study was limited to a specific strain of rats and may not fully represent human conditions.
Participant Demographics
Male OLETF and LETO rats aged 16 and 32 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website